Clinical Trials Directory

Trials / Completed

CompletedNCT01947673

Mechanisms of Intradialytic Hypertension

Sympathetic Regulation in Intradialytic Hypertension

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Patients with end-stage renal disease (ESRD) are at significantly higher risk for death due to cardiovascular disease. Those with paradoxical increases in blood pressure (BP) during hemodialysis (HD), defined as intradialytic hypertension (IDH), are at even greater risk of cardiovascular mortality. This study seeks to determine the mechanisms that underlie IDH, and whether mindfulness meditation might improve BP during dialysis in these patients. The investigators will first determine if increased adrenaline levels during volume removal contributes to IDH. The investigators will then determine lack of suppression of adrenaline levels in the setting of a high BP also contributes to IDH. This will be done by manipulating blood pressure by using small amounts of vasoactive drugs, and determining if an appropriate response in adrenaline levels occurs. Lastly, the investigators will determine if an intradialytic mindfulness meditation program improves BP and adrenaline levels in ESRD patients with IDH.

Conditions

Interventions

TypeNameDescription
OTHERMindfulness Meditation
OTHERHealth Education

Timeline

Start date
2013-09-01
Primary completion
2017-11-01
Completion
2017-11-01
First posted
2013-09-20
Last updated
2021-07-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01947673. Inclusion in this directory is not an endorsement.